Century Therapeutics Inc (IPSC)

Apr 03, 2025

H.C. Wainwright cuts Century Therapeutics target to $2 By Investing.com - Investing.com Canada

Apr 03, 2025

Apr 03, 2025

American Century Companies Inc. Raises Position in Denali Therapeutics Inc. (NASDAQ:DNLI) - Defense World

Apr 03, 2025

Mar 30, 2025

Guggenheim Reiterates Buy Rating for Century Therapeutics (NASDAQ:IPSC) - Defense World

Mar 30, 2025

Mar 28, 2025

What is Chardan Capital’s Estimate for IPSC FY2025 Earnings? - Defense World

Mar 28, 2025

Mar 25, 2025

Century Therapeutics (IPSC) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

Mar 25, 2025

Mar 25, 2025

Century Therapeutics (NASDAQ:IPSC) Price Target Lowered to $7.00 at Chardan Capital - Defense World

Mar 25, 2025

Mar 25, 2025

William Blair Issues Optimistic Forecast for IPSC Earnings - The AM Reporter

Mar 25, 2025

Mar 24, 2025

Carnival To Rally Around 48%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga

Mar 24, 2025

Mar 24, 2025

Q1 EPS Estimate for Century Therapeutics Boosted by Analyst - Defense World

Mar 24, 2025

Mar 24, 2025

Chardan Cuts Price Target on Century Therapeutics to $7 From $11, Keeps Buy Rating - MarketScreener

Mar 24, 2025

Mar 23, 2025

Century Therapeutics Announces Strategic Pipeline Shift and 2024 Financial Results - MSN

Mar 23, 2025

Mar 23, 2025

Guggenheim Lowers Century Therapeutics (NASDAQ:IPSC) Price Target to $5.00 - Defense World

Mar 23, 2025

Mar 23, 2025

Piper Sandler Cuts Century Therapeutics (NASDAQ:IPSC) Price Target to $2.00 - Defense World

Mar 23, 2025

Mar 22, 2025

Guggenheim cuts Century Therapeutics target to $5, keeps Buy rating By Investing.com - Investing.com Canada

Mar 22, 2025

Mar 22, 2025

What is William Blair’s Estimate for IPSC Q3 Earnings? - Defense World

Mar 22, 2025

Mar 21, 2025

Demystifying Century Therapeutics: Insights From 4 Analyst Reviews - Benzinga

Mar 21, 2025

Mar 20, 2025

Century Therapeutics Reports 2024 Financial Results and Strategic Updates - TipRanks

Mar 20, 2025

Mar 20, 2025

Leerink Partners Adjusts Price Target on Century Therapeutics to $8 From $13, Keeps Outperform Rating - Marketscreener.com

Mar 20, 2025

Mar 20, 2025

Elevation Oncology stops work on ADC, lays off workers; AstraZeneca’s CEPI funding - Endpoints News

Mar 20, 2025

Mar 19, 2025

Century Therapeutics, Inc. (IPSC) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Mar 19, 2025

Mar 19, 2025

Century Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 19, 2025

Mar 19, 2025

Century Therapeutics Announces Pipeline Re-Prioritization to Focus on Transformational Programs and Extends Cash Runway into Q4 2026 - Nasdaq

Mar 19, 2025

Mar 19, 2025

Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire

Mar 19, 2025

Mar 19, 2025

Century Therapeutics Secures 2-Year Cash Runway with $220M War Chest - StockTitan

Mar 19, 2025

Mar 16, 2025

Brokerages Set Century Therapeutics, Inc. (NASDAQ:IPSC) Price Target at $10.00 - Defense World

Mar 16, 2025

Mar 13, 2025

Century therapeutics officer sells shares worth $1,451 By Investing.com - Investing.com South Africa

Mar 13, 2025

Mar 13, 2025

Century Therapeutics SVP sells $762 in stock By Investing.com - Investing.com South Africa

Mar 13, 2025

Mar 12, 2025

Century therapeutics CEO sells shares to cover tax obligations By Investing.com - Investing.com South Africa

Mar 12, 2025

Mar 12, 2025

Century therapeutics CEO sells shares to cover tax obligations - Investing.com

Mar 12, 2025

Mar 12, 2025

Century Therapeutics COO Farid Adrienne sells $1,450 in stock - Investing.com India

Mar 12, 2025

Mar 12, 2025

Century therapeutics officer sells shares worth $1,451 - Investing.com

Mar 12, 2025

Mar 12, 2025

Century Therapeutics SVP sells $762 in stock - Investing.com

Mar 12, 2025

Mar 12, 2025

Century Therapeutics COO Farid Adrienne sells $1,450 in stock By Investing.com - Investing.com UK

Mar 12, 2025

Mar 11, 2025

Verrica Pharmaceuticals Inc. (VRCA) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Mar 11, 2025

Mar 07, 2025

Layoff Tracker: Atea Pharmaceuticals Cuts 25% of Workforce - BioSpace

Mar 07, 2025

Mar 06, 2025

Century Therapeutics (IPSC) Expected to Announce Quarterly Earnings on Thursday - Defense World

Mar 06, 2025

Mar 05, 2025

CAR T-cell Therapy Clinical Trial Pipeline Experiences - GlobeNewswire

Mar 05, 2025

Mar 05, 2025

CAR T-cell Therapy Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain - GlobeNewswire Inc.

Mar 05, 2025

Mar 01, 2025

Century Therapeutics faces Nasdaq delisting over share price By Investing.com - Investing.com Australia

Mar 01, 2025

Mar 01, 2025

Century Therapeutics faces Nasdaq delisting over share price - Investing.com India

Mar 01, 2025

Feb 28, 2025

Century Therapeutics Receives Nasdaq Notice For Bid Price Deficiency -February 28, 2025 at 04:20 pm EST - Marketscreener.com

Feb 28, 2025

Feb 20, 2025

Century Therapeutics Executive Sells Shares to Cover Tax Obligations - TradingView

Feb 20, 2025

Feb 20, 2025

Century Therapeutics CEO sells shares worth $27,179 - Investing.com

Feb 20, 2025

Feb 20, 2025

Century Therapeutics CEO sells shares worth $27,179 By Investing.com - Investing.com UK

Feb 20, 2025